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Background: The importance of the maternal-infant dyad in the genesis of nonalcoholic fatty liver disease
(NAFLD) is of increasing interest. The Avon Longitudinal Study of Parents and Children (ALSPAC) showed that
at age 24, 1 in 5 had NAFLD measured by transient elastography and controlled attenuation parameter (CAP).
Our aim was to investigate the association between breastfeeding duration and maternal pre-pregnancy BMI
on offspring NAFLD in young adulthood.
Methods: 4021 participants attended clinic for FibroScan and CAP measurement using Echosens 502 Touch .
440 participants with Alcohol Use Disorders were excluded. Offspring of 100 non-singleton pregnancies
were excluded. 2961 valid CAP measurements for NAFLD were analysed. Exposures of interest were breast-
feeding of any duration, 6months exclusive breastfeeding, and maternal pre-pregnancy BMI. Multivariable
regression models estimated the odds of NAFLD at 24 years. We performed a paternal negative control test
to explore residual confounding in the analyses of pre-pregnancy BMI.
Findings: There was a modest inverse association of exclusive and non-exclusive breastfeeding 6 months
having a protective effect on NAFLD in offspring (OR 0¢92 [95%CI 0¢66-1¢27] and OR 0¢90 [0¢67-1¢21] respec-
tively).The odds of offspring NAFLD in overweight pre-pregnancy maternal BMI and paternal BMI was OR
2¢09 [1¢62-2¢68] and OR 1¢33 [95%CI 1¢07-1¢65] respectively, with the ratio of effect sizes OR 1¢57 [1¢11-
2¢22]. Similarly, odds of offspring NAFLD with obese pre-pregnancy maternal BMI and paternal BMI was OR
2¢66 [1¢71-4¢14] and OR 1¢35 [0¢91-2¢00] respectively, with the ratio of effect sizes OR 1¢98 [1¢05-3¢74].
Interpretation: Higher maternal pre-pregnancy BMI was associated with offspring NAFLD, having accounted
for shared parental confounding. We did not replicate previous work that found a strong association between
breastfeeding and NAFLD.
Funding:Medical Research Council UK, Alcohol Research UK, David Telling Charitable Trust
Crown Copyright © 2021 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/)Keywords:
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In the last decade there has been an increasing interest in the role
of early life exposures, in utero and postnatally, in priming the livers
of offspring to develop non-alcoholic fatty liver disease (NAFLD)
within the complex maternal-infant dyad. Two areas of focus of
research have been the exposures of breastfeeding duration and
maternal pre-pregnancy weight.The value of breastfeeding and its benefits to infants is widely rec-
ognised amongst the scientific community and general public, includ-
ing a reduction in infections and sudden infant death syndrome [1-4].
Different infant feeding practices have been studied in terms of the
developmental origins of health and disease, but the evidence
remains uncertain for many outcomes [4,5]. Several studies have
demonstrated a protective association of breastfeeding
against NAFLD, in part related to generating a favourable gut micro-
biome [6-8].
Multiple possible physiological mechanisms have been suggested
for how maternal obesity may influence NAFLD genesis in offspring.
Murine models have demonstrated that maternal obesity exacerbates
Research in context panel
Evidence before this study
Non-alcoholic fatty liver disease (NAFLD) is the commonest
liver condition in the western world, closely linked to the
worldwide obesity health crisis. Previous studies have sug-
gested breastfeeding for longer periods, particularly 6 months
exclusively, was protective against children getting NAFLD as
teenagers, whilst mothers having obesity increases the odds of
their children going on to develop NAFLD.
Added value of this study
In one of the largest to date to examine these relationships, we
were unable to demonstrate evidence longer breastfeeding
duration was protective against offspring developing NAFLD.
We did find an overweight or obese BMIs in mothers does con-
tribute to children developing NAFLD in addition to a child’s
environment, despite accounting for the shared parental con-
founding using a parental negative control test.
Implications of all the available evidence
This study demonstrates an early life effect in offspring of indi-
viduals with an overweight or obese BMI pre-pregnancy in
developing NAFLD. In doing so, it supports the role of the
maternal infant dyad in NAFLD pathogenesis, thus illustrating
the pervasive intergenerational consequences of obesity. This
highlights the importance of public health strategies designed
to make it easier for individuals to make healthier choices
regarding diet and exercise, in tackling the obesity epidemic.
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tion in offspring fed with a hypercalorific obesogenic diet [9]. Previ-
ously, McCurdy and colleagues demonstrated that high fat diet
exposure affected offspring in utero, associated with hepatic oxidative
stress in the third trimester, mediating NAFLD development in infant
primates [10]. Maternal obesity may also influence infant NAFLD
development via their microbiome. For example, germ-free mice
colonised with stool from infants born to obese mothers versus nor-
mal weight mothers, demonstrated increased hepatic gene expres-
sion of endosplasmic reticulum stress, with hepatic periportal and
lobular inflammation consistent with the histological features of pae-
diatric NAFLD [11].
Importantly, the interplay between maternal pre-pregnancy body
mass index (BMI) and breastfeeding is complex with breastfeeding
duration has been repeatedly demonstrated to be lower in mothers
who are overweight or have obesity [12-14]. In addition, breastmilk
composition could differ between mothers with obesity compared to
those with a normal BMI [15,16], although the role of breastmilk
components in shaping future offspring health remains unclear.
One of the largest attempts to interrogate the association between
breastfeeding duration and maternal pre-pregnancy BMI with off-
spring NAFLD used the Raine birth cohort in Western Australia.
Ayonrinde and colleagues demonstrated 6 months exclusive breast-
feeding was associated with a lower odds of NAFLD outcomes in late
adolescents (17years) and pre-pregnancy obesity more than doubled
odds of NAFLD outcomes in offspring in late adolescence [6]. Longer
breastfeeding duration was also associated with lower serum gamma
glutamyl transferase (GGT) and triglycerides by the age of 17 years,
whilst early introduction of supplementary formula, but not compli-
mentary feeding, was associated with offspring NAFLD [6]. The same
cohort also identified sexual dimorphism in NAFLD development. For
example, socioeconomic status at birth and paternal obesity werePlease cite this article as: K.W. Abeysekera et al., Association of maternal
parental negative control study, The Lancet Regional Health - Europe (202strongly associated with NAFLD specifically in male adolescent off-
spring [17].
The Avon Longitudinal Study of Parents and Children (ALSPAC) is
a large prospective birth cohort, based in Bristol, United Kingdom
(UK) [18]. ALSPAC assessed the cohort as young adults (n=4021;
mean age 24 years) using transient elastography (FibroScan) and
controlled attenuated parameter (CAP) and found NAFLD prevalence
to be over 20% [19].
Using existing data on maternal BMI and infant feeding practices
at ALSPAC, we aim to replicate the previous Raine cohort study and
test whether exposures of any breastfeeding, 6 months exclusive
breastfeeding, and maternal pre-pregnancy BMI are associated with
NAFLD in young adulthood. To strengthen a causal inference, we
used a negative control approach by testing the association of pater-
nal pre-pregnancy BMI and comparing this effect size to that of
maternal pre-pregnancy BMI.
2. Materials and methods
2.1. Study population
The Avon Longitudinal Study of Parents and Children (ALSPAC) is
a prospective birth cohort study from southwest England [18,20].
The study website contains details of all available data through a fully
searchable data dictionary and variable search tool (www.bristol.ac.
uk/alspac/researchers/our-data). Briefly, ALSPAC invited pregnant
women in Avon, UK with expected delivery dates between April 1,
1991 and December 31, 1992 into the cohort [21]. The initial number
of pregnancies enrolled is 14,541. Of these initial pregnancies, there
was a total of 14,676 foetuses, resulting in 14,062 live births and
13,988 children who were alive at 1 year of age.
When the oldest children were approximately 7 years of age, an
attempt was made to bolster the initial sample with eligible cases
who had failed to join the study originally. Following 3 further phases
of recruitment, this resulted in an additional 913 children being
enrolled. The total sample size for analyses using any data collected
after the age of seven is therefore 15,454 pregnancies, resulting in
15,589 foetuses. Of these 14,901 were alive at 1 year of age [21].
Ethical approval for the study was obtained from the ALSPAC
Ethics and Law Committee and the Local Research Ethics Committees.
Consent for biological samples has been collected in accordance with
the Human Tissue Act (2004). Informed consent for use of data col-
lected via questionnaires and clinics was obtained from participants
following the recommendations of the ALSPAC Ethics and Law Com-
mittee at the time.
Between June 2015 and October 2017, 10018 remaining “active”
ALSPAC study participants were invited to the “Focus@24+” clinic
(see Fig. 1). Of 10018 participants invited, 40¢1% (n=4021/10018)
attended; mean age 24.0 years (SD 0¢8; IQR 23-25 years; 1507 males,
2510 females).
1060 participants were excluded from the final analysis. 293 non-
core participants (i.e. not enrolled in the original recruitment phase
of ALSPAC) did not have recorded maternal measures. 97 twins and
triplets were excluded as non-singleton pregnancies are indepen-
dently associated with lower breastfeeding duration [22-24]. 440
participants attending the F@24+ clinic had evidence of Diagnostic
and Statistical Manual of Mental Disorders-5 (DSM-V) criteria for
alcohol use disorder (AUD) were also excluded from analysis [25]. 94
participants did not attend the FibroScan session. Of those who did
99 had insufficient information e.g. did not have 10 valid CAP meas-
urements. Finally, 37 participants withdrew consent to continue
being part of ALSPAC. Thus, 2961 participants were included in this
study.
Study data were collected and managed using REDCap electronic
data capture tools hosted at University of Bristol [26]. In line with
ALSPAC confidentiality policy, any analysed groups with less thanpre-pregnancy BMI and breastfeeding with NAFLD in young adults: a
1), https://doi.org/10.1016/j.lanepe.2021.100206
Fig. 1. Flow diagram of study
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expressed can include zero.
In the F@24+ clinic no one was reported to have viral hepatitis or
taking nucleoside analogues/direct-acting antivirals. In the F@24+
clinic, there were less than 5 participants identified with: autoim-
mune hepatitis on azathioprine, or autoimmune hepatitis/primary
sclerosing cholangitis overlap syndrome on prednisolone, mycophe-
nolate mofetil, ursodeoxycholic acid, who were not removed as this
was a general population study.
2.2. Outcomes
Prior to Focus@24+ clinic attendance, participants were fasted for
a minimum of 6 hours or overnight before blood tests and subse-
quent transient elastography.
Imaging. In the F@24+ clinic participants were assessed with transient
elastography (FibroScan, Echosens 502 Touch, Echosens, Paris) and
controlled attenuation parameter (CAP). These are a standardised non-
invasive measure of fibrosis and quantifying steatosis in NAFLD [27,28].
CAP score cut off values for different grades of steatosis for both groups
were derived from a meta-analysis on CAP technology [28]. Ten valid
readings within the range of 100-400dB/m were required to derive a
CAP score. NAFLDwas defined as248dB/m (S1 equivalent steatosis).
Serology. Fasted blood tests analysed included liver function: ala-
nine transaminase (ALT), aspartate aminotransferase (AST) and
g-glutamyl transferase (GGT). Lipid profiles were taken including
cholesterol, triglycerides, low-density lipoprotein-cholesterol (LDL-
C), very low-density lipoprotein (VLDL-C), and high-density lipopro-
tein (HDL). Glucose and insulin levels were also sent and used to cal-
culate the homeostasis model assessment for insulin resistance
(HOMA-IR), using the equation HOMA-IR score = (Fasting insulin
[mU/ml] x Fasting glucose [mmol/l])/22¢5 [29,30].
As a secondary analysis we sought to evaluate if there was a dif-
ference in liver enzyme levels and metabolic markers betweenPlease cite this article as: K.W. Abeysekera et al., Association of maternal
parental negative control study, The Lancet Regional Health - Europe (202participants with NAFLD who were breastfed for more or less than 6
months, as the previous Raine cohort study had noted some differ-
ence including lower serum GGT, triglycerides, and HOMA-IR in par-
ticipants breastfed for 6months [6].
2.3. Exposures
The data used in this study were collected from ALSPAC mothers
during pregnancy and over the index child’s first year of life. Data on
method of infant feeding, including introduction of supplementary
milk formula and complimentary feeding, were obtained from ques-
tionnaires completed by mothers when the index child was 6 and 15
months of age [31]. Two categorical variables were created. “Any
breastfeeding duration” was trichotomized into never breastfed (ref-
erent), non-exclusive breastfeeding <6 months, and non-exclusive
breastfeeding 6months. “Exclusive breastfeeding 6 months” was
compared to having never breastfed (referent), and mixed feeding (i.
e. supplementary milk formula) or duration of breastfeeding <6
months combined. Exclusive breastfeeding 6 months was defined
as no reported supplementary milk formulas (including cow’s milk,
soya, hypoallogenic and follow-on formula) in the first 6 months. A
cut-off of 6 months breastfeeding was specified to facilitate direct
comparison with the Raine cohort analysis.
In questionnaires at around 18 weeks of gestation women
reported their pre-pregnancy weight and height and this was used to
calculate maternal pre-pregnancy BMI (correlations between BMI
based on weight and height reported by the women and BMI based
on weight and height extracted from the first antenatal clinic visit
were high; Pearson correlation coefficient: 0¢9).
2.4. Confounders
Confounders were defined a priori based on prior evidence of
them being known or plausible causes of the exposure and outcomepre-pregnancy BMI and breastfeeding with NAFLD in young adults: a
1), https://doi.org/10.1016/j.lanepe.2021.100206
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founders for maternal pre-pregnancy BMI: occupational social class
(derived from maternal and partner questionnaires at 12- and 18-
weeks’ gestation respectively), maternal age, smoking in pregnancy.
The following were considered confounders for breastfeeding: social
class, maternal age, smoking in pregnancy, maternal pre-pregnancy
BMI, birthweight.3. Statistical analysis
Mean serology results for participants with and without NAFLD
based on CAP value in the F@24+ clinic were compared using univari-
able regression for normally distributed data (cholesterol, LDL-C,
HDL). Wilcoxon rank sum was used to compare differences between
non-normally distributed data (ALT, AST, GGT, HOMA-IR, VLDL-C, tri-
glycerides). Univariable regression models were used to examine the
exposure of supplementary formula and complimentary feeding on
outcomes of offspring NAFLD in the first 6 months. Confounder
adjusted multivariable logistic regression models were used to exam-
ine the associations of pre-pregnancy BMI (in mothers and fathers),
exclusive breastfeeding for more or less than 6 months, and any
breastfeeding duration with NAFLD.
3.1. Paternal negative control
Negative control studies in epidemiology compare results from
the hypothesized (real) association and a negative control association
where either the exposure is changed to an exposure that does not
plausibly cause the outcome, or vice versa [32-34]. In studies of the
developmental origins of disease, paternal exposure has been
increasingly used as a negative control for maternal exposure as data
are often available on the same exposures in the father that are
potentially causal intrauterine factors in mothers [35,36]. Here we
compared confounder adjusted paternal BMI categories of normal,Table 1
Characteristics of exposures amongst participants (n=2961).
Variable S0 (n=
Sex Male (n=1070) 789 (7
Female (n=1891) 1561
Maternal pre-pregnancy BMI BMI <25kg/m2 (n=2196) 1795
Overweight (25 -<30kg/m2) (n=371) 261 (7
Obesity (30kg/m2) 71
Paternal BMI BMI <25kg/m2 (n=2196) 972 (8
Overweight (25 -<30kg/m2) (n=371) 638 (7
Obesity (30kg/m2) 106
Breastfeeding Never breastfed (n=404) 307 (7
Mixed feeding (n=1747) 1398
Exclusive breastfeeding for 6months
(n=584)
471 (8
Maternal smoking during pregnancy No (n=2446) 1955
Yes (n=467) 359 (7
Maternal age (years) Mean (SD) 29.5 (
Maternal education Lower than O-level (n=502) 374 (7
O-level (n=987) 765 (7
Higher education (n=1385) 1132
Social class IV-V (partly skilled and unskilled
occupation)
65
III (non-manual and manual occupation)
(n=879)
686 (7
II (managerial and technical occupation)
(n=1264)
1000
I (professional occupation) (n=530) 435 (8
Birthweight (grams) Mean (SD) 3413¢
Steatosis grade based on CAP score ranges from S0-S3. S0 <248 dB/m (<10% steatosis); S1
steatosis [moderate]); and S3 280 dB/m or more (66% steatosis [severe])
* Pearson’s Chi2 test
< Univariable logistic regression
Please cite this article as: K.W. Abeysekera et al., Association of maternal
parental negative control study, The Lancet Regional Health - Europe (202overweight and obesity associations with offspring NAFLD to the
same associations of maternal BMI categories with offspring NAFLD.
For this parental negative control comparison, we also mutually
adjusted each parents’ exposure for the same exposure in the other
parent as failing to do this can result in bias in the presence of assor-
tative mating [37]. To simplify the paternal negative control test,
maternal and paternal BMI were dichotomised in two models: (1)
normal BMI vs overweight & obese BMI and (2) normal and over-
weight BMI vs obese BMI. In each model maternal and paternal BMI
exposures were mutually adjusted for, following which effect size
estimates were compared at the different thresholds (overweight
and obese BMI). The null hypothesis was there is no difference
between the maternal and paternal estimates.
3.2. Dealing with missing data
This study only included participants with complete CAP data and
imputed missing exposure and confounder data, with this being the
highest for maternal pre-pregnancy BMI (9¢2% of participants did not
have this measure). Statistical analysis was performed using Stata MP
15¢1. (For further details on the imputation strategy see Supplemen-
tary Methods).
4. Results
2961 participant with valid CAP results were eligible for analysis
(63¢9% female). Overall, 20¢7% (95%CI 19¢2-22¢1%) of participants
attended the Focus@24+ clinic had NAFLD (S1 equivalent steatosis),
with 10¢1% having S3 equivalent steatosis CAP measurements (>66%
steatosis).
Characteristics of the main exposures analysed are summarised in
Table 1. Offspring NAFLD prevalence within male and female sex
were interrogated (see Table 2). There did not appear to be any rela-
tionship between longer breastfeeding duration between male off-
spring participants with or without NAFLD (p=0¢27). No relationship2350; 79¢4%) S1 (n=215; 7¢3%) S2 (n=99; 3¢3%) S3 (n=297; 10¢0%)
3¢7%) 93 (8¢7%) 44 (4¢1%) 144 (13¢5%) p<0¢0001*
(82¢5%) 122 (6¢4%) 55 (2¢9%) 153 (8¢1%)
(81¢7%) 144 (6¢6%) 73 (3¢3%) 184 (8¢4%) p<0¢0001*
0¢3%) 39 (10¢5%) 14 (3¢8%) 57 (15¢4%)
14 <5 32
2¢0%) 87 (7¢3%) 36 (3¢0%) 90 (7¢6%) p<0¢0001*
6¢7%) 62 (7¢4%) 35 (4¢2%) 97 (11¢7%)
11 <5 28
6¢0%) 33 (8¢2%) 15 (3¢7%) 49 (12¢1%) p=0¢15*
(80¢0%) 130 (7¢4%) 60 (3¢4%) 159 (9¢1%)
0¢6%) 33 (5¢6%) 14 (2¢4%) 66 (11¢3%)
(79¢9%) 175 (7¢1%) 81 (3¢3%) 235 (9¢6%) p=0¢40*
6¢9%) 35 (7¢5%) 17 (3¢4%) 56 (12¢0%)
4¢6) 28.7 (4¢5) 28.5 (4¢4) 28.8 (4¢8) p=0¢001<
4¢5%) 46 (9¢2%) 19 (3¢8%) 63 (12¢5%) p=0¢03*
7¢5%) 78 (7¢9%) 38 (3¢8%) 106 (10¢7%)
(81¢7%) 90 (6¢5%) 39 (2¢8%) 124 (9¢0%)
9 <5 6 p=0¢43*
8¢0%) 64 (7¢3%) 33 (3¢7%) 97 (11¢0%)
(79¢1%) 95 (7¢5%) 35 (2¢8%) 134 (10¢6%)
2¢1%) 36 (6¢8%) 18 (3¢4%) 41 (7¢7%)
7 (513¢4) 3475 (554¢8) 3434 (457¢0) 3479 (509¢5) p=0¢02<
248 to <268 dB/m (10%<33% steatosis [mild]); S2 268 to <280 dB/m (33%<66%
pre-pregnancy BMI and breastfeeding with NAFLD in young adults: a
1), https://doi.org/10.1016/j.lanepe.2021.100206
Table 2
Comparison of offspring characteristics by sex corresponding with presence or absence of NAFLD
Male participants Female participants
No NAFLD (n=789) NAFLD (n=281) No NAFLD (n=1561) NAFLD (n=330)
Breastfeeding pattern Never breastfed 68¢2% 31¢8% p=0¢27* 79¢8% 20¢2% p=0¢28*
Mixed feeding 75¢0% 25¢0% 83¢1% 16¢9%
Exclusive breastfeeding for 6months 73¢7% 26.2% 84¢4% 15¢6%
Maternal pre-pregnancy BMI
(n=2688)
21¢9 (20¢5-24¢0) 22¢7 (20¢9-25¢3) p=0¢001z 21¢8 (20¢3-23¢6) 22¢9 (21¢0-26¢0) p<0¢0001z
Paternal BMI
(n=2167)
24¢6 (22¢8-26¢6) 25¢0 (23¢4-27¢2) p=0¢01z 24¢6 (22¢8-26¢5) 25¢4 (23¢5-28¢1) p<0¢0001z
Social class (n=2757) IV-V (partly skilled and unskilled
occupation)
80¢0% 20¢0% p=0¢47* 75¢9% 24¢1% p=0¢13*
III (non-manual and manual
occupation)
70¢7% 29¢3% 81¢8% 18¢2%
II (managerial and technical
occupation)
74¢9% 25¢1% 81¢6% 18¢4%
I (professional occupation) 75¢0% 25¢0% 82¢4% 17¢6%
z Wilcoxon rank sum test
* Pearson’s Chi2 test
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(p=0¢28). Both in male and female offspring participants, maternal
pre-pregnancy BMI was strongly associated with offspring NAFLD
(p=0¢001 and p<0¢0001 respectively). Similarly paternal BMI was
also strong associated with offspring in both male and female sexes
(p=0¢01 and p<0¢0001 respectively). Finally, no difference in socio-
economic status was identified between male and female offspring
with and without NAFLD (p=0¢47 and p=0¢13 respectively).
4.1. Any Breastfeeding
Complete data on patterns of breastfeeding existed on 2409 par-
ticipants when restricting to those with available CAP measurements.
Participants were categorised ordinally into those that were not
breastfed (n=342/2409), those that breastfed (with or without mixed
feeding) for less than 6 months (n=1048/2409) and those that
breastfed (with or without mixed feeding) for 6months (n=1019/
2409) as a dose response exposure. (see Table 3.) There was a weak
association of breastfeeding duration 6months being associated
with lower odds of NAFLD, compared to <6 months or no breastfeed-
ing (19¢0% vs 20¢6% vs 24¢0% respectively; unadjusted OR 0¢78 (0¢58-
1¢04; p=0¢09). However, this association attenuated when adjusted
for confounders including social class, maternal age, smoking in preg-
nancy, birthweight and the pre-pregnancy BMI exposure variable (OR
0¢92 [0¢67-1¢26]; p=0¢60). Findings were similar following the use of
multiple imputation (OR 0¢90 [0¢67-1¢21]; p=0¢50).4.2. Exclusive breastfeeding 6 months
(see Table 3.) When interrogating 6months exclusive breast-
feeding, participants were categorised into those who never
breastfed (n=342/2409), those with mixed feeding or duration of
breastfeeding <6 months combined (n=1544/2409), and those who
exclusively breastfed for 6months (n=523/2409). Lower prevalence
of NAFLD were seen amongst participants who were exclusively
breastfed for 6months, compared to participants who received
mixed feeding and those who never breastfed, but the confidence
interval included the null (19¢3% vs 20¢0% vs 24¢0% respectively; OR
0¢78 [0¢56-1¢09]; p=0¢14). Effect estimates were attenuated further
after adjusting for confounders including social class, maternal age,
smoking in pregnancy, birthweight, and the pre-pregnancy BMI
exposure variable (0¢89 [0¢63-1¢27]; p=0¢53). This did not alter fol-
lowing imputation of a complete dataset (0¢92 [0¢66-1¢27]; p=0¢60).
Please cite this article as: K.W. Abeysekera et al., Association of maternal
parental negative control study, The Lancet Regional Health - Europe (2024.3. Timing of introduction of supplementary milk formula and
complementary feeding
(see Table 4.) In the first 6 months, no association was identified
between the month supplementary milk formula was introduced and
the presence of NAFLD in univariable analysis (OR 0¢97 [0¢93-1¢01;
p=0¢13]). Whilst there was a stronger association between timing of
complementary feeding being commenced in the first 6 months and
lower odds of NAFLD, the confidence interval again included the null
(OR 0¢91 [0¢82-1¢01; p=0¢07]).
4.4. Pre-pregnancy maternal BMI
(see Table 3.) 13¢8% (n=371/2688) of mothers were overweight,
whilst 4¢5% had pre-pregnancy obesity (n=121/2688). Presence of
NAFLD in offspring ranged from 18¢3% amongst mother with a
BMI<25 kg/m2 to 41¢3% amongst mother with pre-pregnancy obe-
sity.
Complete data on maternal pre-pregnancy BMI was available for
2505 participants when interrogating NAFLD outcomes. Mothers’
BMI was categorised into normoweight (<25kg/m2; n=2051/2505),
overweight (25 BMI <30kg/m2; n=346/2505), and obese (30kg/
m2; n=108/=2505). Crude associations of overweight and obese
maternal pre-pregnancy BMI with offspring NAFLD outcomes were
OR 2¢00 ([1¢55-2¢58]; p<0¢0001) and OR 3¢28 ([2¢20-4¢88];
p<0¢0001) respectively. Following adjustment for confounders
including social class, maternal age and smoking in pregnancy and
imputation to a complete data set overweight and obese maternal
pre-pregnancy BMI with offspring NAFLD outcomes were OR 1¢84
([1¢44-2¢37]; p<0¢0001) and OR 3¢06 ([2¢11-4¢42]; p<0¢0001) respec-
tively.
4.5. Paternal negative control
A negative control test entails the comparison of magnitude of the
maternal and paternal association estimates within a mutually
adjusted model. (see Table 5.) For completeness Table 5 contains
crude estimates. 2316 participants had paternal BMI data.
Prior to mutual adjustment, parental pre-pregnancy BMI was
dichotomised into (1) BMI<25kg/m2 vs BMI 25kg/m2(overweight
and obese) and (2) BMI<30kg/m2 vs BMI 30kg/m2 (obese). In model
(1) the odds of offspring NAFLD in overweight/obese pre-pregnancy
maternal BMI and paternal BMI was OR 2¢09 [95%CI 1¢62-2¢68;
p<0¢0001] and OR 1¢33 [95%CI 1¢07-1¢65; p=0¢01] respectively, with
the ratio of effect sizes OR 1¢57 [95%CI 1¢11-2¢22; p=0¢01]. Similarly,
in model (2) the odds of offspring NAFLD with obese pre-pregnancypre-pregnancy BMI and breastfeeding with NAFLD in young adults: a
1), https://doi.org/10.1016/j.lanepe.2021.100206
Table 3
Exposures associated with presence of NAFLD (n=2961)




























Number of participants with complete data available = 2505 p<0¢0001y p<0¢0001y
2 Paternal BMI Underweight or Normal 18¢0% Referent
Overweight 23¢3% 1¢39 [1¢12-1¢73;
p=0¢003]
Obese 28¢9% 1¢85 [1¢26-2¢72;
p=0¢002]
Number of participants with complete data available = 2069 p=0¢0007y
3 6 months Exclusive
breastfeeding
Never breastfed 24¢0% Referent Referent Referent
Mixed feeding
[imputed result]
20¢0% 0¢81 [0¢62-1¢07; p=0¢14] 0¢85 [0¢64-1¢13; p=0¢26] 0¢88 [0¢66-1¢18; p=0¢40]
0¢89 [0¢68-1¢16;
p=0¢38]
 6months exclusive breast-
feeding
[imputed result]
19¢3% 0¢78 [0¢56-1¢09; p=0¢14] 0¢83 [0¢59-1¢18; p=0¢31] 0¢89 [0¢63-1¢27; p=0¢53]
0¢92 [0¢66-1¢27;
p=0¢60]
Number of participants with complete data available = 2409 p=0¢16y p=0¢50y p=0¢70y
4 Any breastfeeding Never breastfed 24¢0% Referent Referent Referent
<6 months
[imputed result]





19¢.0% 0¢78 [0¢58-1¢04; p=0¢09] 0¢85 [0¢62-1¢17; p=0¢32] 0¢92 [0¢67-1¢26; p=0¢60]
0¢90 [0.67-1¢21;
p=0¢50]
Number of participants with complete data available = 2409 p=0¢25y p=0¢50y p=0¢63y
y Likelihood ratio test
ARTICLE IN PRESS
JID: LANEPE [m5G;September 5, 2021;7:23]
6 K.W. Abeysekera et al. / The Lancet Regional Health - Europe 00 (2021) 100206maternal BMI and paternal BMI was OR 2¢66 [95%CI 1¢71-4¢14;
p<0¢0001] OR 1¢35 [95%CI 0¢91-2¢00; p=0¢014] respectively, with the
ratio of effect sizes OR 1¢98 [95%CI 1¢05-3¢74; p=0¢04].4.6. Association of duration of breastfeeding with serum liver enzymes,
cardiometabolic markers, and young adults with NAFLD
(see Table 6.) Median ALT, AST, and GGT levels were compared
between participants identified with NAFLD who had been breastfed
exclusively for 6 months vs < 6 months breast/mixed feeding, with
no difference found (p=0¢21, 0¢12 and 0¢66 respectively). Similarly,
there was no difference in mean cholesterol, LDL-C, HDL, and medianTable 4
Timing of introduction of milk formula feeding, complementary feeding, and





Month `N % NAFLD N % NAFLD
0 936 22¢0 50 30¢0
1 212 19¢3 41 19¢5
2 291 21¢3 230 23¢0
3 292 21¢2 1613 20¢7
4 202 20¢3 719 18¢8
5 185 16¢8 111 21¢6
6 673 19¢3 27 14¢8
OR 0¢97 [0¢93-1¢01; p=0¢13]< OR 0¢91 [0¢82-1¢01; p=0¢07] <
< Univariable logistic regression
Please cite this article as: K.W. Abeysekera et al., Association of maternal
parental negative control study, The Lancet Regional Health - Europe (202triglyceride levels between groups (p=0¢86, 0¢22, 0¢30 and 0¢40
respectively). Median HOMA-IR values amongst participants with
NAFLD who received exclusive breastfeeding for 6 months were
higher compared to participants with NAFLD who breastfed for <6
months (3¢5 vs 2¢8, p=0¢07) with both groups in the insulin resistance
range. This is despite similar levels of obesity (38¢4% vs 38¢7% respec-
tively) and similar sex distribution (56¢2% bs 50¢6% respectively)
amongst the 2 groups.
Further analyses including analysing liver fibrosis (liver stiffness
measurement of 7.9kPa equivalent to F2 fibrosis) as the outcome
with the same exposures can be found in Supplementary Results.
5. Discussion
5.1. Main findings
We found evidence of a specific early life effect of overweight and
obese maternal pre-pregnancy BMI with higher odds of offspring
NAFLD in young adulthood, that could not be explained by the shared
parental confounding structure. Whilst we found an association with
maternal pre-pregnancy BMI and NAFLD outcomes in offspring, this
was also the case when modelling the association of paternal BMI as
a negative control exposure. Therefore, whilst there may be an early
life effect, this is in addition to environmental factors in the genesis
NAFLD.
We did not find evidence that longer breastfeeding duration and
6 months exclusive breastfeeding duration were associated with a
lower odds of NAFLD in offspring by young adulthood. We found
insufficient evidence supporting the hypothesis that mixed feeding ispre-pregnancy BMI and breastfeeding with NAFLD in young adults: a
1), https://doi.org/10.1016/j.lanepe.2021.100206
Table 5
Paternal negative control test. Crude and adjusted OR refer to outcomes of NAFLD.
Model Independent variable Crude OR [95% CI] Mutually Adjusted OR [95% CI] Ratio of effect sizes[95% CI]
1 Pre-pregnancy maternal BMI Underweight or Normal (n=2333) Referent Referent 1¢57 [1¢11-2¢22; p=0¢011] y
Overweight or obese (n=536) 2¢15 [1¢74-2¢68; p<0¢0001] 2¢09 [1¢62-2¢68; p<0¢0001]
Paternal BMI Underweight or Normal (n=1267) Referent Referent
Overweight or obese (n=1049) 1¢45 [1¢18-1¢79; p<0¢0001] 1¢33 [1¢07-1¢65; p=0¢01]
2 Pre-pregnancy maternal BMI Not obese (n=2736) Referent Referent 1¢98 [1¢05-3¢74; p=0¢036] y
Obese (n=133) 2¢83 [1¢95-4¢12; p<0¢0001] 2¢66 [1¢71-4¢14; p<0¢0001]
Paternal BMI Not obese (n=2153) Referent Referent
Obese (n=163) 1¢61 [1¢11-2¢33; p=0¢012] 1¢35 [0¢91-2¢00; p=0¢14]
y ORs are ratio of mutually adjusted ORs between maternal and paternal BMI exposure on NAFLD outcomes in offspring at 24 years.
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compared to exclusive breastfeeding.
5.2. Strength and limitations
This study can only comment on the relationships of maternal pre-
pregnancy BMI and breastfeeding duration with NAFLD outcomes in
the context of singleton pregnancies as we removed twin and multiple
pregnancies to limit bias, as those pregnancies are associated with
lower breastfeeding duration [22-24]. By treating BMI as a categorical
variable to replicate the previous Raine cohort analysis, we accepted a
loss of power for not treating BMI as a continuous variable.
Our diagnosis of NAFLD was based on controlled attenuation
parameter diagnosis in the absence of harmful alcohol use. We
acknowledge that cut-off values for CAP are validated in adults with
histologically proven liver disease and these results should be inter-
preted in that context. However, in our large population study, gold
standard liver biopsy was not ethically viable.
Whilst individuals with alcohol use disorder were removed from
this analysis, ALSPAC did not collect data on grams of alcohol con-
sumed by participants. Therefore, it is possible that participants with
excess daily alcohol consumption (>30g/day in men and >20g/day in
women) were included in the analysis.
We accepted that increased maternal pre-pregnancy BMI and
breastfeeding cannot be considered entirely independent of each
other. In addition to breastfeeding duration being lower in mothers
with obesity, murine models showed in offspring of mice control-
diets, when breastfed by obese mice on high-fat diets, had evidence
of increased hepatic tumour necrosis factor, interleukin-6 expression,
and triglyceride levels highlighting a difference in breastmilk com-
position between mothers with obesity and those with normal BMI
[12, 38, 39]. Maternal pre-pregnancy BMI was included as a con-
founder in regression models evaluating breastfeeding as an expo-
sure to replicate and compare with the previous Raine cohortTable 6








ALT (10-35U/l) Median (IQR) 15¢8 (12¢4-20¢2) 27¢4 (
AST (10-35U/l) Median (IQR) 24¢8 (21¢3-30¢2) 26¢3 (
GGT (IU/l) (<40 U/l) Median (IQR) 19 (14-30) 20.5 (
HOMA-IR (<1¢68) Median (IQR) 3¢5 (1¢8-5¢2) 2¢8 (1
Cholesterol (<5¢2mmmol/l) Mean (SD) 4¢6 (0¢9) 4¢5 (0
Triglycerides (<1.7mmol/l) Median (IQR) 1¢1 (0¢7-1¢7) 1¢1 (0
LDL-C (mmol/l) Mean (SD) 2¢6 (0¢8) 2¢8 (0
VLDL-C (mmol/l) Median (IQR) 0¢5 (0¢3-0¢8) 0¢5 (0
HDL (>1¢45mmol/l) Mean (SD) 1¢3 (0¢4) 1¢3 (0
y T-test
z Wilcoxon rank sum test
Please cite this article as: K.W. Abeysekera et al., Association of maternal
parental negative control study, The Lancet Regional Health - Europe (202analysis. Despite utilising a large birth cohort, our study remained
underpowered to assess the relationship between breastfeeding
duration and outcomes of NAFLD in offspring (see Supplementary
Methods for power calculation). Therefore, we cannot definitively
comment on a lack of protective effect of longer breastfeeding dura-
tion.
The World Health Organisation advised exclusive breastfeeding
duration for 4 to 6 months during the 1990s and changed their stance
in 2001 to 6 months exclusive breastfeeding [40,41]. Overall, 21¢2%
(n=620/2928) of our participants were exclusively breastfed for 6
months in the early 1990s, which is substantially higher than 1%
figure quoted in the 2010 UK Infant Feeding Survey, and the Raine
cohort 7¢4% [6,42]. Despite this relatively high number of exclusively
breastfed participants, we were unable to elucidate a strong protec-
tive effect of longer exclusive breastfeeding duration for NAFLD
development.
The ALSPAC Focus@24 clinic had a large clinic non-attendance,
with only 40¢1% of participants attending. Therefore, the ALSPAC
birth cohort may not be entirely representative of the wider popula-
tion [18]. The demographic profile of the catchment area in south-
west England, and the differential attrition, has created an over-
representation of affluent groups and an under-representation of eth-
nic minorities, with ALSPAC over 97% Caucasian [18]. Thus, it is
unclear how our results apply to patients of other ethnicities with
NAFLD. Higher maternal educational attainment is strongly associ-
ated with longer breastfeeding duration [43,44]. Despite this we
could not demonstrate a strong association for the protective benefits
of longer breastfeeding duration.
5.3. Other evidence
To the best of our knowledge, this is one of the largest studies to
interrogate the relationship between breastfeeding, maternal pre-










18¢9-49¢8) 0¢21z 18¢9 (14¢7-26¢2) 19.1 (14¢1-27¢6) 0¢92z
20¢9-36¢0) 0.12z 23¢9 (20¢9-28¢2) 23¢7 (20¢5-28¢5) 0¢76z
15-31) 0¢66z 15 (12-20) 16 (12-20) 0¢94z
¢8-3¢8) 0¢07z 1¢6 (1¢1-2¢2) 1¢6 (1¢1-2¢3) 0¢61z
¢8) 0¢86y 4¢4 (0¢8) 4¢4 (0¢8) 0¢82y
¢7-1¢6) 0¢40z 0¢8 (0¢6-1¢1) 0¢8 (0¢6-1¢1) 0¢92z
¢8) 0¢22y 2¢3 (0¢7) 2¢4 (0¢7) 0¢47y
¢3-0¢7) 0¢10z 0¢4 (0¢3-0¢5) 0¢4 (0¢3-0¢5) 0¢81z
¢3) 0¢30y 1¢7 (0¢4) 1¢6 (0¢4) 0¢03y
pre-pregnancy BMI and breastfeeding with NAFLD in young adults: a
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for maternal pre-pregnancy BMI leading to NAFLD in offspring.
Whilst there was an association between increased paternal BMI and
offspring NAFLD, when we mutually adjusted for maternal and pater-
nal BMI and compared effect size estimates, there still appeared to be
an increased association between overweight and obese maternal
BMI and offspring NAFLD. This lends support to an early life effect
increasing odds of NAFLD in offspring amongst mothers with ele-
vated pre-pregnancy BMI, independent of environmental factors.
In a similar birth cohort, the Raine cohort (n=1170) based in West-
ern Australia, 15¢2% had NAFLD based on ultrasound assessment. Our
findings evaluating the early life effects of maternal pre-pregnancy
were consistent with the Raine Cohort in relation to maternal pre-
pregnancy obesity and NAFLD outcomes (OR 2¢29 [1¢21-4¢32];
p=0¢01). Our paternal negative control test supported this associa-
tion. In addition, a meta-analysis of current literature of maternal risk
factors for paediatric NAFLD risk supports our findings regarding the
relationship of elevated maternal pre-pregnancy BMI with offspring
NAFLD [45]. The Raine cohort found 6months exclusive breastfeed-
ing to be protective vs <6 months breastfeeding without supplemen-
tary milk (OR 0¢64 [0¢43-0¢94], p=0¢02); whereas after adjustment we
did not find evidence of a similar protective effect with a larger sam-
ple size. However, our assessment of a protective breastfeeding effect
is limited by being underpowered.
Ayonrinde and colleagues also identified sexual dimorphism in
the association of parental factors on NAFLD in offspring [17]. They
found paternal obesity to be associated with male offspring NAFLD
only. Female offspring NAFLD with independently associated with
higher maternal pre-pregnancy BMI. Furthermore, lower parental
socioeconomic status was associated with NAFLD in male offspring.
We did not demonstrate such sexual dimorphism in our cohort anal-
ysis at 24 years or when our participants were 17.8 years during the
first assessment for NAFLD using ultrasound [46]. This could be
related to an overrepresentation of female participants in our cohort,
who account for 63.9% of our cohort compared to 49.4% of the Raine
cohort. In addition, NAFLD is far more prevalent in ALSPAC male par-
ticipants compared to female participants, a reversal of the relation-
ship seen in the previous Raine cohort analysis. This could be related
to ALSPAC examining young adults as opposed to adolescents. Suzuki
et al analysed paediatric biopsy proven NAFLD identifying a relation-
ship between increasing pubertal stage and possibly worse histologi-
cal features of NAFLD, although the study was underpowered to
identify sex differences [47].
Our results contrast existing epidemiological literature which
largely negates the association of pre-pregnancy BMI, breastfeeding
duration, and outcomes of the related outcomes of childhood adipos-
ity and obesity. The Promotion of Breastfeeding Intervention Trial
(PROBIT) randomised controlled trial involving over 17,000 offspring
did not demonstrate a difference in adiposity between infants with
substantially greater durations and exclusivity of breastfeeding than
the control arm at aged 6¢5 years or 11¢5 years [48,49]. One of the
largest systematic reviews and meta-analyses (including 105 studies)
to interrogate the association between breastfeeding and offspring
being overweight or obese found only a modest pooled OR 0¢87
[0¢76-0¢99], involving 1500 participants [50].
Whilst we found no evidence that longer breastfeeding durations
were protective for offspring developing NAFLD, other studies have
suggested it may have a protective effect for mothers within a mater-
nal-infant dyad. Using an older American cohort study, Coronary
Artery Risk Development in Young Adults, Ajmera and colleagues
demonstrated that mothers who breastfed for longer durations
(>6months) had >50% reduction in NAFLD outcomes compared to
those who had breastfed for 0-1months, after adjusting for age, eth-
nicity education level and baseline BMI [51]. The mechanism postu-
lated for this finding was of increased maternal basal metabolic rate
associated with lactation, increasing insulin sensitivity [51,52].Please cite this article as: K.W. Abeysekera et al., Association of maternal
parental negative control study, The Lancet Regional Health - Europe (2025.4. Implications
The wide-ranging early life benefits of breastfeeding are indisput-
able. Whilst our findings are insufficient to conclusively rule out an
effect, we found little evidence that longer breastfeeding durations or
exclusive breastfeeding  6 months is protective for offspring devel-
oping NAFLD. With higher-income countries such as the UK having
shorter breastfeeding duration, further studies are needed to clarify if
a true protective benefit exists.
Similarly, we have demonstrated evidence for an early life effect
associated with elevated maternal pre-pregnancy BMI, in addition to
environmental factors, that contributes to offspring developing
NAFLD as young adults. We must collectively address the obesogenic
environment our patients live in and support them in behavioural
change interventions to improve their diet and increase exercise
whilst promoting policies that minimise perpetuation of unhealthy
eating patterns. Ultimately this will reduce the risk of patients and
their children developing advanced NAFLD fibrosis and cirrhosis.
Funding
The UK Medical Research Council and Wellcome (Grant ref:
217065/Z/19/Z) and the University of Bristol provide core support for
ALSPAC. This work was undertaken with the support of the MRC and
Alcohol Research UK (MR/L022206/1), and the David Telling Charita-
ble Trust. We also acknowledge support from The Centre for the
Development and Evaluation of Complex Interventions for Public
Health Improvement (DECIPHer), a UKCRC Public Health Research
Centre of Excellence (joint funding (MR/KO232331/1) from the Brit-
ish Heart Foundation, Cancer Research UK, Economic and Social
Research Council, Medical Research Council, the Welsh Government
and the Wellcome Trust, under the auspices of the UK Clinical
Research Collaboration, the NIHR School of Public Health Research,
NIHR Health Protection Research Unit in Behavioural Science and
Evaluation and NIHR Biomedical Research Centre at the University
Hospitals Bristol NHS Foundation Trust. LZ, DAL and HM work in a
unit that receive funds from the University of Bristol and Medical
Research Council (MC_UU_00011/6) and DAL’s contribution to this
paper is also supported by the Bristol NIHR Biomedical Research Cen-
tre. DAL (NF-0616-10102) and MH (G123511-101) are NIHR Senior
Investigators. None of the funders influenced the research question,
analysis plan or interpretation of results. The views expressed in this
paper are those of the authors and not necessarily any listed funders.
Authors Contributions
KWMA (study design, data analysis, manuscript preparation); JGO
(study design, critical review); PMD (advice on negative control study
and critical review); (GSF (data analysis, critical review) LZ (critical
review); FHG (critical review); DAL (advice on negative control study
and critical review); JH (study design, data acquisition, data analysis,
critical review); MH (study design, critical review, supervised entire
project).
Declaration of Interest
DAL has received support from Medtronic Ltd and Roche Diagnos-
tics for research unrelated to that presented here. MH has received
lecturer honoraria from MSD and Gilead. Other authors declared no
conflicts of interest.
Acknowledgements
We are extremely grateful to all the families who took part in this
study, the midwives for their help in recruiting them, and the whole
ALSPAC team, which includes interviewers, computer and laboratorypre-pregnancy BMI and breastfeeding with NAFLD in young adults: a
1), https://doi.org/10.1016/j.lanepe.2021.100206
ARTICLE IN PRESS
JID: LANEPE [m5G;September 5, 2021;7:23]
K.W. Abeysekera et al. / The Lancet Regional Health - Europe 00 (2021) 100206 9technicians, clerical workers, research scientists, volunteers, manag-
ers, receptionists and nurses. This publication is the work of the
authors who will serve as guarantors for the contents of this paper.
Supplementary materials
Supplementary material associated with this article can be found
in the online version at doi:10.1016/j.lanepe.2021.100206.
References
[1] Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics
2012;129(3):e827–41.
[2] Chen A, Rogan WJ. Breastfeeding and the risk of postneonatal death in the United
States. Pediatrics 2004;113(5):e435–9.
[3] Owen CG, Martin RM, Whincup PH, Smith GD, Cook DG. Effect of infant feeding on
the risk of obesity across the life course: a quantitative review of published evi-
dence. Pediatrics 2005;115(5):1367–77.
[4] Victora CG, Bahl R, Barros AJD, França GVA, Horton S, Krasevec J, et al. Breastfeed-
ing in the 21st century: epidemiology, mechanisms, and lifelong effect. The Lan-
cet 2016;387(10017):475–90.
[5] Rollins NC, Bhandari N, Hajeebhoy N, Horton S, Lutter CK, Martines JC, et al. Why
invest, and what it will take to improve breastfeeding practices? The Lancet
2016;387(10017):491–504.
[6] Ayonrinde OT, Oddy WH, Adams LA, Mori TA, Beilin LJ, de Klerk N, et al. Infant
nutrition and maternal obesity influence the risk of non-alcoholic fatty liver dis-
ease in adolescents. J Hepatol 2017;67(3):568–76.
[7] Nobili V, Bedogni G, Alisi A, Pietrobattista A, Alterio A, Tiribelli C, et al. A protec-
tive effect of breastfeeding on the progression of non-alcoholic fatty liver disease.
Arch Dis Child 2009;94(10):801–5.
[8] Ho NT, Li F, Lee-Sarwar KA, Tun HM, Brown BP, Pannaraj PS, et al. Meta-analysis of
effects of exclusive breastfeeding on infant gut microbiota across populations. Nat
Commun 2018;9(1):4169.
[9] Mouralidarane A, Soeda J, Visconti-Pugmire C, Samuelsson AM, Pombo J, Marag-
koudaki X, et al. Maternal obesity programs offspring nonalcoholic fatty liver dis-
ease by innate immune dysfunction in mice. Hepatology 2013;58(1):128–38.
[10] McCurdy CE, Bishop JM, Williams SM, Grayson BE, Smith MS, Friedman JE, et al.
Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman pri-
mates. J Clin Invest 2009;119(2):323–35.
[11] Soderborg TK, Clark SE, Mulligan CE, Janssen RC, Babcock L, Ir D, et al. The gut
microbiota in infants of obese mothers increases inflammation and susceptibility
to NAFLD. Nat Commun 2018;9(1):4462.
[12] Oddy WH, Li J, Landsborough L, Kendall GE, Henderson S, Downie J. The associa-
tion of maternal overweight and obesity with breastfeeding duration. J Pediatr
2006;149(2):185–91.
[13] Donath SM, Amir LH. Does maternal obesity adversely affect breastfeeding initia-
tion and duration? J Paediatr Child Health 2000;36(5):482–6.
[14] Amir LH, Donath S. A systematic review of maternal obesity and breastfeeding
intention, initiation and duration. BMC Pregnancy Childbirth 2007;7:9.
[15] Enstad S, Cheema S, Thomas R, Fichorova RN, Martin CR, O'Tierney-Ginn P, et al.
The impact of maternal obesity and breast milk inflammation on developmental
programming of infant growth. Eur J Clin Nutr 2020.
[16] Leghi GE, Netting MJ, Middleton PF, Wlodek ME, Geddes DT, Muhlhausler ABS.
The impact of maternal obesity on human milk macronutrient composition: A
systematic review and meta-analysis. Nutrients 2020;12(4).
[17] Ayonrinde OT, Adams LA, Mori TA, Beilin LJ, de Klerk N, Pennell CE, et al. Sex dif-
ferences between parental pregnancy characteristics and nonalcoholic fatty liver
disease in adolescents. Hepatology 2018;67(1):108–22.
[18] Boyd A, Golding J, Macleod J, Lawlor DA, Fraser A, Henderson J, et al. Cohort Pro-
file: the 'children of the 90s'the index offspring of the Avon Longitudinal Study
of Parents and Children. Int J Epidemiol 2013;42(1):111–27.
[19] Abeysekera KWM, Fernandes GS, Hammerton G, Portal AJ, Gordon FH, Heron J,
et al. Prevalence of steatosis and fibrosis in young adults in the UK: a population-
based study. The Lancet Gastroenterology & Hepatology; 2020.
[20] Fraser A, Macdonald-Wallis C, Tilling K, Boyd A, Golding J, Davey Smith G, et al.
Cohort Profile: the Avon Longitudinal Study of Parents and Children: ALSPAC
mothers cohort. Int J Epidemiol 2013;42(1):97–110.
[21] Northstone K, Lewcock M, Groom A, Boyd A, Macleod J, Timpson N, et al. The Avon
Longitudinal Study of Parents and Children (ALSPAC): an update on the enrolled
sample of index children in 2019. Wellcome Open Res 2019;4:51.
[22] Yokoyama Y, Wada S, Sugimoto M, Katayama M, Saito M, Sono J. Breastfeeding
Rates Among Singletons, Twins and Triplets in Japan: A Population-Based Study.
Twin Research and Human Genetics 2012;9(2):298–302.
[23] Damato EG, Dowling DA, Standing TS, Schuster SD. Explanation for cessation of
breastfeeding in mothers of twins. J Hum Lact 2005;21(3):296–304.
[24] Ostlund A, Nordstrom M, Dykes F, Flacking R. Breastfeeding in preterm and term
twinsmaternal factors associated with early cessation: a population-based
study. J Hum Lact 2010;26(3):235–41 quiz 327-9.
[25] American Psychiatry Association. Diagnostic and statistical manual of mental dis-
orders. 5th edition. APA; 2013.Please cite this article as: K.W. Abeysekera et al., Association of maternal
parental negative control study, The Lancet Regional Health - Europe (202[26] Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic
data capture (REDCap)a metadata-driven methodology and workflow process
for providing translational research informatics support. J Biomed Inform
2009;42(2):377–81.
[27] Wong VW, Vergniol J, Wong GL, Foucher J, Chan HL, Le Bail B, et al. Diagnosis of
fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver
disease. Hepatology 2010;51(2):454–62.
[28] Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de Ledinghen V, et al. Individual
patient data meta-analysis of controlled attenuation parameter (CAP) technology
for assessing steatosis. J Hepatol 2017;66(5):1022–30.
[29] Sarafidis PA, Lasaridis AN, Nilsson PM, Pikilidou MI, Stafilas PC, Kanaki A, et al.
Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indi-
ces in patients with hypertension and type II diabetes. J Hum Hypertens 2007;21
(9):709–16.
[30] Shashaj B, Luciano R, Contoli B, Morino GS, Spreghini MR, Rustico C, et al. Refer-
ence ranges of HOMA-IR in normal-weight and obese young Caucasians. Acta Dia-
betol 2016;53(2):251–60.
[31] Martin RM, Ness AR, Gunnell D, Emmett P, Davey Smith G, Team AS. Does breast-
feeding in infancy lower blood pressure in childhood? The Avon Longitudinal
Study of Parents and Children (ALSPAC). Circulation 2004;109(10):1259–66.
[32] Sanderson E, Macdonald-Wallis C, Davey, Smith G. Negative control exposure
studies in the presence of measurement error: implications for attempted effect
estimate calibration. Int J Epidemiol 2018;47(2):587–96.
[33] Lawlor DA, Tilling K, Davey Smith G. Triangulation in aetiological epidemiology.
Int J Epidemiol 2016;45(6):1866–86.
[34] Lipsitch M, Tchetgen Tchetgen E, Cohen T. Negative controls: a tool for detecting
confounding and bias in observational studies. Epidemiology 2010;21(3):383–8.
[35] Brand JS, Gaillard R, West J, McEachan RRC, Wright J, Voerman E, et al. Associa-
tions of maternal quitting, reducing, and continuing smoking during pregnancy
with longitudinal fetal growth: Findings from Mendelian randomization and
parental negative control studies. PLoS Med 2019;16(11):e1002972.
[36] Santos Ferreira DL, Williams DM, Kangas AJ, Soininen P, Ala-Korpela M, Smith GD,
et al. Association of pre-pregnancy body mass index with offspring metabolic
profile: Analyses of 3 European prospective birth cohorts. PLoS Med 2017;14(8):
e1002376.
[37] Madley-Dowd P, Rai D, Zammit S, Heron J. Simulations and directed acyclic
graphs explained why assortative mating biases the prenatal negative control
design. J Clin Epidemiol 2020;118:9–17.
[38] Oben JA, Mouralidarane A, Samuelsson AM, Matthews PJ, Morgan ML, McKee C,
et al. Maternal obesity during pregnancy and lactation programs the develop-
ment of offspring non-alcoholic fatty liver disease in mice. J Hepatol 2010;52
(6):913–20.
[39] Wesolowski SR, Kasmi KC, Jonscher KR, Friedman JE. Developmental origins of
NAFLD: a womb with a clue. Nat Rev Gastroenterol Hepatol 2017;14(2):81–96.
[40] WHO. World Health Organisation's infant feeding recommendation. Weekly Epi-
demiological Record 1995;70:119–20.
[41] WHO. Infant and young child feeding. A tool for assessing national practices, poli-
cies and programmes. World Health Organization; 2003.
[42] McAndrew FT, J.; Fellows, L.; Large, A.; Speed, M.; Renfrew, M.J. . Infant Feeding
Survery 2010 Health and Social Care Information Centre. 2012.
[43] Bertini G, Perugi S, Dani C, Pezzati M, Tronchin M, Rubaltelli FF. Maternal educa-
tion and the incidence and duration of breast feeding: A prospective study. Jour-
nal of Pediatric Gastroenterology and Nutrition 2003;37(4):447–52.
[44] Flacking R, Nyqvist KH, Ewald U. Effects of socioeconomic status on breastfeeding
duration in mothers of preterm and term infants. Eur J Public Health 2007;17
(6):579–84.
[45] Querter I, Pauwels NS, De Bruyne R, Dupont E, Verhelst X, Devisscher L, et al.
Maternal and perinatal risk factors for pediatric non-alcoholic fatty liver disease:
A systematic review. Clin Gastroenterol Hepatol 2021.
[46] Lawlor DA, Callaway M, Macdonald-Wallis C, Anderson E, Fraser A, Howe LD, et al.
Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in
adolescence: a cross-sectional study of 1874 general population adolescents. J
Clin Endocrinol Metab 2014;99(3):E410–7.
[47] Suzuki A, Abdelmalek MF, Schwimmer JB, Lavine JE, Scheimann AO, Unalp-Arida
A, et al. Association between puberty and features of nonalcoholic fatty liver dis-
ease. Clin Gastroenterol Hepatol 2012;10(7):786–94.
[48] Kramer MS, Matush L, Vanilovich I, Platt RW, Bogdanovich N, Sevkovskaya Z, et al.
Effects of prolonged and exclusive breastfeeding on child height, weight, adipos-
ity, and blood pressure at age 6.5 y: evidence from a large randomized trial. Am J
Clin Nutr 2007;86(6):1717–21.
[49] Martin RM, Patel R, Kramer MS, Guthrie L, Vilchuck K, Bogdanovich N, et al. Effects
of promoting longer-term and exclusive breastfeeding on adiposity and insulin-
like growth factor-I at age 11.5 years: a randomized trial. JAMA 2013;309
(10):1005–13.
[50] Horta BL, Loret de Mola C, Victora CG. Long-term consequences of breastfeeding
on cholesterol, obesity, systolic blood pressure and type 2 diabetes: a systematic
review and meta-analysis. Acta Paediatr 2015;104(467):30–7.
[51] Ajmera VH, Terrault NA, VanWagner LB, Sarkar M, Lewis CE, Carr JJ, et al. Longer
lactation duration is associated with decreased prevalence of non-alcoholic fatty
liver disease in women. J Hepatol 2019;70(1):126–32.
[52] Gunderson EP, Lewis CE, Wei GS, Whitmer RA, Quesenberry CP, Sidney S. Lacta-
tion and changes in maternal metabolic risk factors. Obstet Gynecol 2007;109
(3):729–38.pre-pregnancy BMI and breastfeeding with NAFLD in young adults: a
1), https://doi.org/10.1016/j.lanepe.2021.100206
